Morgan Stanley raised the firm’s price target on Lazard (LAZ) to $61 from $47 and keeps an Underweight rating on the shares. With the M&A cycle “gaining steam,” the firm estimates M&A volumes to fully revert back to three decade averages versus nominal GDP in 2027 and is rolling its valuation year from 2026 to 2027, the analyst tells investors in a note on the Midcap Advisors group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LAZ:
- Lazard Announces Leadership Change in Asset Management
- Lazard Appoints Dmitry Shevelenko to Board of Directors
- Keefe Bruyette upgrades Lazard on improving flow narrative
- Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
- Coca-Cola (KO) Eyes Costa Coffee Sale despite Billions in Potential Losses